Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Why This Well-Timed Strategy is Forcing Them to Re-evaluate a Junior Oil Play in Texas

By Prodigy NewsG2 Energy Corp. is a Canadian, publicly-traded company (CSE:GTOO,OTCQB:GTGEF, FKN:UD9) focused on identifying and developing OVERLOOKED opportunities in the energy sector.The...
Research | July 14, 2022 |

Global Central Banks Move To Keep The Party Rolling Onward – Part I

The recent news that the US Fed, China and many of the global central banks are continuing to make efforts to lower rates and spark further consumer spending and economic activity is reminiscent of the late 2010~2013 global economic recovery efforts. This was a time when the e...
Chris Vermeulen | August 14, 2019 |

Explorer's Upcoming Resource Estimate Update Should 'Show Growth'

The potential of this company's asset is discussed in an Echelon Wealth Partners report. In a Jan. 10 research note, Echelon Wealth Partners analyst Gabriel Gonzalez purported that Revival Gold Inc.'s (RVG:TSX.V) updated Beartrack and Arnett Creek resource estimate,...
Streetwise Reports | January 17, 2020 |

Meeting the New Green Economy’s Voracious Appetite for Lithium

(Click image to play video) As the battery metals market continues to skyrocket – and lithium in particular – new, reliable sources of this critical metal are in extremely high demand. Enter ION Energy Ltd. ( TSX-V. ION , OTCMKTS: IONGF , FF:5YB ) – an e...
Dave Jackson | April 19, 2021 |

High Quality Canadian Gold & Silver Projects; Promising Drill Results

Investors eyeing opportunities in the hot gold and silver market may have a lot of options, but few check as many boxes as Affinity Metals Corp. ( TSX-V.AFF , OTC: ARIZF , Forum ) when it comes to quality projects, solid results, and stable share structure. Focused...
Dave Jackson | October 19, 2020 |

Buzz on the Bullboards: Heavy Debating on Larger Hubs

Significant moves on several of the largest Bullboard hubs at Stockhouse have set off furious debates on the future direction of these companies. While a couple of these companies have been basking in good news, the majority of the heated discussions this week concern companie...
Stockhouse Editorial | May 2, 2019 |

Nevada’s Gold Market Is Ready to Boom, Here’s a Solid Stock To Watch

(Image via NV Gold Corp.) The state of Nevada produces around 175 tonnes of gold every year and if it were a country, it would be the fifth largest gold producer in the world. Two of the richest areas in Nevada for gold production are the Cortez Gold Belt and the Wa...
Jonathon Brown | April 28, 2021 |

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial

Ovid Therapeutics' shares are trading 25% higher today after the company reported positive initial data from its ENDYMION soticlestat phase 2 trial for patients with developmental and epileptic encephalopathies. Shares of Ovid Therapeutics Inc. (OVID:NASDAQ) are tra...
Streetwise Reports | September 25, 2019 |

Why Did ImmunoGen Plummet 32%?

This biotechnology company, which focuses on the treatment of cancer, received some feedback from the FDA that upset investors on Wednesday. ImmunoGen Inc.'s (IMGN:NASDAQ) shares closed down 32.06% on the NASDAQ Wednesday after announcing the United States ...
Streetwise Reports | May 21, 2019 |

PDS Biotech Collaborating with Merck in Phase 2 Cancer Trial

This morning PDS Biotechnology Corp. shares are trading 38% higher after reporting that it will enter into a clinical collaboration with Merck pairing the firm's PDS0101 with KEYTRUDA for patients with recurrent or metastatic head and neck cancer and high-risk HPV16 infection....
Streetwise Reports | October 4, 2019 |
1 2 3 4 5 6 7 8 9 10 ...